CALLIDITAS THERAPEUTICS-ADR (CALT)
US13124Q1067 - ADR
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -373.06M | -421.94M | -524.46M | -379.72M | -28.02M | |||
| Depreciation Amortization | 48.73M | 12.91M | N/A | N/A | 1.82M | |||
| Change In Working Capital | -164.08M | 49.33M | -3.81M | 55.07M | -45.30M | |||
| Interest Paid | 94.50M | 35.25M | 5.43M | 393.00K | 325.00K | |||
| Taxes Paid | 22.75M | 7.39M | 3.95M | 528.00K | N/A | |||
| Other non cash items | 53.75M | 48.35M | 66.68M | 15.46M | 486.00K | |||
| OPERATING CASH FLOW | -434.65M | -311.35M | -461.59M | -309.18M | -71.01M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -12.79M | -2.51M | -22.65M | N/A | -16.18M | |||
| Other Investing Activity | -957.00K | -2.63M | -1.69M | -172.61M | -1.89M | |||
| INVESTING CASH FLOW | -13.74M | -5.14M | -24.34M | -172.61M | -18.07M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 199.65M | 480.87M | 179.09M | -3.97M | -1.65M | |||
| Stock Issued/Repurchased | 0.00 | 95.12M | 324.00M | 950.64M | 213.15M | |||
| Other Financing Activity | -1.00K | -1.00K | -67.93M | -178.11M | -12.66M | |||
| FINANCING CASH FLOW | 199.65M | 575.99M | 435.16M | 768.56M | 198.84M | |||
| Exchange Rate Effect | -26.61M | 34.09M | 9.97M | -44.01M | -2.39M | |||
| CHANGE IN CASH | -275.36M | 293.59M | -40.80M | 242.76M | 107.37M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -434.65M | -311.35M | -461.59M | -309.18M | -71.01M | |||
| Capital Expenditure | -12.79M | -2.51M | -22.65M | N/A | -16.18M | |||
| FREE CASH FLOW | -447.44M | -313.87M | -484.24M | -309.18M | -87.19M | |||
All data in SEK